Skip to main content
Raoul Concepcion, MD, Urology, Nashville, TN

RaoulSConcepcionMDFACS

Urology Nashville, TN

Surgical Oncology

Chief Science Officer, U.S. Urology Partners

Dr. Concepcion is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Concepcion's full profile

Already have an account?

Summary

  • Urologist Raoul Concepcion Explains Gleason Score And Gleason Grade - YT

    Raoul Concepcion, a urologist with Urology Associates in Nashville, Tenn., explains Gleason score and Gleason grade as it relates to a prostate cancer diagnosis

    Survey Shows Growing Use of Genetic Testing in Prostate Cancer Management in the

    Raoul S. Concepcion, MD It is known that genetic testing plays a role in the management of prostate cancer, but community practices are still trying to understa

    New Considerations for Oligometastatic Prostate Cancer

    Raoul S. Concepcion, MD, FACS, presented "New Considerations for Oligometastatic Prostate Cancer" during the 29th Annual International Prostate Cancer Update on

    AR Resistance Mechanisms: Focusing on Variants and Testing

    Raoul S. Concepcion, MD, FACS, presented "AR Resistance Mechanisms: Focusing on Variants and Testing" during the 29th Annual International Prostate Cancer Updat

    Dr. Concepcion on Potential for Immunotherapy in CRPC

    Raoul S. Concepcion, MD, FACS, director, Comprehensive Prostate Center, discusses the potential for immunotherapy in the treatment of patients with castration-r

    Managing Advanced Prostate Cancer in the Future

    Transcript: Raoul S. Concepcion, MD, FACS: I want to thank all of the panelists, because I think this has been extremely informative. But before we end this dis

    Dr. Concepcion on Barriers to Genetic Testing in Community Urology Practices

    Raoul S. Concepcion, MD, FACS, director, Comprehensive Prostate Center, discusses barriers to genetic testing for patients with prostate cancer as identified by

    Prognostic Biomarker Tests for Prostate Cancer

    Biomarker tests can be a useful addition to a prostate specific antigen (PSA) screening for determining who needs an initial biopsy, the appropriateness of a re

    Heritable Prostate Cancer: Germline vs Somatic Mutations

    Transcript: Raoul S. Concepcion, MD, FACS: Hello, and thank you for joining us today for this OncLive® Peer Exchange® panel discussion on personalizing therapy

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Urology, 1986 - 1990
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Surgery, 1984 - 1986
  • The University of Toledo College of Medicine
    The University of Toledo College of MedicineClass of 1984
  • The University of Toledo College of Medicine
    The University of Toledo College of MedicineB.S., Biology, Magna Cum Laude, 1979

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2018 - 2025
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Past President, Founding Board Member Large Urology Group Practice Association, 2008-2012
  • CMS Meaningful Use Stage 1 Certification Allscripts Professional EHR, Allscripts, 2012
  • The University of Toledo Honors Scholarship 1975
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • The Effect of Local Antibiogram-based Augmented Antibiotic Prophylaxsis on Infection-related Complications Following Prostate Biopsy  
    Concepcion RS, Schaeffer, EM, Shore ND, et al, Reviews in Urology, 3/2019
  • Pharmacokinetic and pharmacodynamic comparison of subcutaneous versus intramuscular leuprolide acetate formulations in male subjects  
    Daniel Saltzstein, Neal D. Shore, Judd W. Moul, Franklin Chu, Raoul Concepcion, Stephan de la Motte, John A. McLane, Stuart Atkinson, Alex Yang, E. David Crawford, Therapeutic Advanced in Urology, 11/22/2017
  • Association between physical activity, lower urinary tract symptoms (LUTS) and prostate volume  
    Fowke JH, Phillips S, Koyama T, Byerly S, Concepcion R, Motley SS, Clark PE, BJU Int., 1/1/2013
  • Join now to see all

Abstracts/Posters

  • Late Administration of Luteinizing Hormone-Releasing Hormone (LHRH) Agonists and the Impact on Testosterone Suppression in the Real-World Management of Prostate Cancer
    Concepcion RS, Crawford ED, Atkinson S, et al, ASCO GU, San Francisco CA, 2/8/2019
  • Impact of enzalutamide vs bicalutamide on health related quality of life (HRQofL) of patients with CRPC: STRIVE study
    RS Concepcion, AJ Armstrong, L Karsh, et al, Genitourinary Cancer Symposium, San Francisco CA, 2/8/2018
  • Head to Head PK and PD Comparison of Subcutaneous vs Intramuscular
    Moul J, Concepcion R, Atkinson S, Society of Government Service Urologists, San Diego CA, 1/23/2017
  • Join now to see all

Lectures

  • The Evolving Prostate Cancer Landscape: PCEC Lecture 
    Nashville TN - 10/10/2019
  • Community Urology Perspective on Germline Testing for Prostate Cancer 
    Philadelphia Prostate Cancer Consensus Conference 2019 - 10/5/2019
  • Current Challenges in the Management of Advanced Prostate Cancer 
    FDUS 2019, Colorado Springs CO - 8/5/2019
  • Join now to see all

Other

  • What Urologists Want to Know: Addressing Current Questions and Controversies in Prostate CA 
    R. Concepcion, L. Gomella, D. Lin, O. Sartor, D. Quinn
    AUA - 5/14/2017

Press Mentions

  • U.S. Urology Partners Names Healthcare Visionary Raoul S. Concepcion, M.D., as Chief Science Officer
    U.S. Urology Partners Names Healthcare Visionary Raoul S. Concepcion, M.D., as Chief Science OfficerJune 22nd, 2021
  • SynDevRx Assembles Prostate Cancer Medical Advisory Board to Oversee Drug Candidate That Targets Link Between Obesity and Prostate Cancer
    SynDevRx Assembles Prostate Cancer Medical Advisory Board to Oversee Drug Candidate That Targets Link Between Obesity and Prostate CancerJanuary 25th, 2021
  • VerdePharmHealth Strengthens Board of Directors and Advisory Panel
    VerdePharmHealth Strengthens Board of Directors and Advisory PanelFebruary 26th, 2020
  • Join now to see all

Committees

  • Prostate Cancer Panel, SUO - CTC 2019 - Present

Professional Memberships

Industry Relationships

  • Consultant, Invitae2018 - Present
  • Consultant, Cellay2016 - Present
  • Consultant, Integra ConnectChief Urologic Clinical Advisor2016 - Present
  • National Speaker, Janssen Pharmaceuticals2013 - Present
  • National Speaker, Astellas, Astellas2012 - Present
  • Consultant, Dendreon2011 - Present
  • Consultant, Merck2019 - 2019
  • Consultant, Sun Pharma2018 - 2019
  • Consultant, Clovis2018 - 2019
  • National Speaker, Pfizer2017 - 2019
  • National Speaker, Amgen2010 - 2019